Skip to main content

Advertisement

Log in

Anti-idiotypic antibody specific for an infectious bursal disease virus-neutralizing monoclonal antibody does not interfere with the virus infection

Brief Report

  • Published:
Archives of Virology Aims and scope Submit manuscript

Summary.

 Infectious bursal disease virus (IBDV) capsid protein, VP2, contains a hypervariable domain that is recognized by virus-neutralizing antibodies. The virus-neutralizing epitope is highly conformation-dependent and the domain is speculated to be involved in the virus-target cell interaction. In this study, a polyclonal anti-idiotypic antibody (anti-id) was generated by the sequential immunization of a rabbit with a virus-neutralizing monoclonal antibody GI-11 which recognizes the VP2 hypervariable domain. Although the anti-id, which mimics the conformational epitope in the VP2 hypervariable domain, was expected to inhibit the virus infection, the anti-id did not interfere with either the virus binding or the infection to the target cell.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received January 30, 2002; accepted May 10, 2002

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yamaguchi, T., Igusa, A., Setiyono, A. et al. Anti-idiotypic antibody specific for an infectious bursal disease virus-neutralizing monoclonal antibody does not interfere with the virus infection . Arch Virol 147, 2017–2023 (2002). https://doi.org/10.1007/s00705-002-0864-9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00705-002-0864-9

Keywords

Navigation